Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Feds Win OK To Join Rapamune Whistleblower Suit
Pharmalot
Friday, October 15, 2010 - 10:44am
tags:
whistleblowers, Rapamune, Wyeth, Pfizer, DOJ
Cheerleaders vs. Graybeards: Abbott Labs Discrimination Case Reveals War in Big Pharma
BNET Pharma
Friday, October 15, 2010 - 10:43am
tags:
age discrimination, Abbott Laboratories
Sanofi Aventis: Clouds Remain Until Genzyme Deal Is Resolved
Seeking Alpha
Friday, October 15, 2010 - 10:41am
tags:
M&A, Genzyme, Sanofi
[video] For All MannKind?
CNBC
Friday, October 15, 2010 - 10:38am
tags:
inhaled insulin, MannKind, Afrezza
Should You Let AstraZeneca Go?
Bloomberg
Friday, October 15, 2010 - 10:37am
tags:
AstraZeneca
Cubist 3Q net income rises as Cubicin sales grow
Yahoo/AP
Friday, October 15, 2010 - 10:36am
tags:
Cubist Pharmaceuticals, earnings
Sanofi MS drug data show relapses cut by 31 pct
Reuters
Friday, October 15, 2010 - 10:35am
tags:
Sanofi, MS, multiple sclerosis, teriflunomide
Drug Regulation: When Yes Means No
Forbes
Friday, October 15, 2010 - 10:29am
tags:
FDA, advisory panels
Two Surprising Big Pharmas That Show Signs of Life
Forbes
Friday, October 15, 2010 - 10:28am
tags:
Novo Nordisk, Bristol-Myers Squibb
J&J Must Pay $257.6 Million Over Risperdal Marketing, Louisiana Jury Says
Bloomberg
Friday, October 15, 2010 - 10:27am
tags:
JNJ, Risperdal, antipsychotics
Forest Labs Sees Large Call Selling
Seeking Alpha
Thursday, October 14, 2010 - 5:21pm
tags:
Forest Labs
Genzyme Says Campath MS Success Helps Justify Higher Sanofi Buyout Offer
Bloomberg
Thursday, October 14, 2010 - 5:19pm
tags:
Genzyme, Campath, MS, multiple sclerosis, M&A, Sanofi
Talecris gets FDA approval for Gamunex-C, a new version of its immune disorder treatment
Yahoo/AP
Thursday, October 14, 2010 - 5:17pm
tags:
Talecris, Gamunex-C, FDA
Is Myriad Genetics About to be Taken Over?
Minyanville
Thursday, October 14, 2010 - 5:16pm
tags:
M&A, Myriad Genetics, Pfizer, Abbott Laboratories, Cephalon, Merck, Inotek
Genzyme sees signs of remission in 5-year MS drug data
Fierce Biotech
Thursday, October 14, 2010 - 11:53am
tags:
MS, multiple sclerosis, Campath, Genzyme
Genzyme to vest stock options if acquired
Bizjournals.com
Thursday, October 14, 2010 - 11:51am
tags:
stock options, Genzyme, M&A, Sanofi
GSK to donate 1B tablets of intestinal-worms drug for children
Bizjournals.com
Thursday, October 14, 2010 - 11:49am
tags:
GSK, donations, albendazole
NICE to compare Tyverb, Herceptin in breast cancer
Fierce Pharma
Thursday, October 14, 2010 - 11:16am
tags:
breast cancer, Tyverb, Herceptin, NICE, GSK
Merck And Johnson & Johnson Arbitration Is Delayed
Pharmalot
Thursday, October 14, 2010 - 11:10am
tags:
JNJ, Merck, arbitration, Remicade, Simponi
Bristol-Myers Drug Gets 2nd Look In Study
Investors.com
Thursday, October 14, 2010 - 11:09am
tags:
Bristol-Myers Squibb, Plavix, Sanofi

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.